GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ABCG2, ACHE, ADRA2A, AKR1B1, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HSD17B1, HSD17B2, KCNH2, KDR, MET, PPARA, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, XDH |
8.10868 |
[BP] GO:0042221 |
response to chemical
|
ABCG2, ADRA2A, AKR1B1, AXL, CA2, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, IGF1R, KCNH2, KDR, MMP2, MMP9, PPARA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
8.04509 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, ESR1, HSD17B1, HSD17B2 |
7.05508 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, GRIK5, GRM5, HSD17B2, IGF1R, MMP2, MMP9, PPARA, RORC, SLC6A4, SRC, TYR |
6.75701 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.61808 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, ESR1, FABP3, FABP4, HSD17B1, HSD17B2, MET, PPARA |
6.48556 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, IGF1R, KDR, MMP2, PPARA, RORC, SLC6A4, SRC, TYR |
6.23075 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADRA2A, AKR1B1, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRIK5, GRM1, GRM5, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
5.71951 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.43823 |
[BP] GO:0044281 |
small molecule metabolic process
|
ABCG2, AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, FABP3, PIM1, PPARA, TYR, XDH |
5.42323 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADRA2A, AKR1B1, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A4, SRC, TERT, XDH |
5.42323 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, RORC |
5.37503 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, CA2, CA7, DRD1, DRD2, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A4 |
5.37503 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, CA2, CA7, DRD1, DRD2, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A4 |
5.37503 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.21354 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, ADRA2A, AKR1B1, CDC25B, CSNK2A1, CYP1B1, DRD2, ESR1, ESRRA, F3, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SLC6A4, SRC, TERT, XDH |
5.21354 |
[BP] GO:0032501 |
multicellular organismal process
|
ADRA2A, AKR1B1, AKR1B10, ALOX5, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F3, FABP4, GRM1, GRM5, GRM8, HSD17B2, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A2, SLC6A4, SRC, TYR |
5.21354 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KCNH2, KDR, MMP2, MMP9, RORC, SLC6A4, SRC, TERT |
5.21354 |
[BP] GO:0042592 |
homeostatic process
|
ABCG2, ADRA2A, AKR1B1, AXL, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, KCNH2, MET, SRC, TERT |
5.11708 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.11637 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.05618 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
4.98237 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADRA2A, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
4.95445 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.90237 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADRA2A, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
4.85921 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC, TERT |
4.73563 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
DRD1, DRD2, GRM1, GRM3, GRM5, GRM8 |
4.69072 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADRA2A, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, GRM1, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
4.65681 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADRA2A, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, GRM1, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
4.64247 |
[BP] GO:0048878 |
chemical homeostasis
|
ABCG2, ADRA2A, AKR1B1, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, KCNH2, MET |
4.56531 |
[BP] GO:0050896 |
response to stimulus
|
ABCG2, ACHE, ADORA3, ADRA2A, AKR1B1, AURKB, AXL, CA2, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD17B2, IGF1R, KCNH2, KDR, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
4.56531 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, FABP3, FABP4, MET, PPARA |
4.45732 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, RORC, SLC6A4, SRC, TYR |
4.43048 |
[BP] GO:0014070 |
response to organic cyclic compound
|
CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FLT3, RORC, SLC6A4, SRC, TYR |
4.40133 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.3936 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, CA2, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SLC6A4, SRC |
4.3936 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.36199 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.35998 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA3, ADRA2A, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, GRIK5, GRM5, IGF1R, KCNA3, KCNH2, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
4.35832 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, CDC25B, CSNK2A1, DRD2, ESR1, F3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, TERT |
4.23901 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD1, DRD2, FABP3, GRIA2, GRIA4, GRIK5, KCNA3, KCNH2, PPARA, SLC1A1, SLC6A2, SLC6A4 |
4.23901 |
[BP] GO:0007193 |
None
|
ADRA2A, DRD2, GRM1, GRM3, GRM5, GRM8 |
4.19929 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.10386 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, AXL, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, RORC, SLC6A4, SRC |
3.96361 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KCNH2, KDR, MMP2, MMP9, PTPN1, RORC, SLC6A4, SRC, TERT |
3.82443 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.82443 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.82443 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA |
3.78201 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.76109 |
[BP] GO:0099536 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.76109 |
[BP] GO:0099537 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.76109 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19, CYP3A4 |
3.7379 |
[BP] GO:0042493 |
response to drug
|
ABCG2, AKR1B1, AXL, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, KCNH2, KDR, SLC6A2, SLC6A4, SRC |
3.66789 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CES1, CYP1A1, CYP1B1, DRD1, DRD2, KDR, SLC6A4, SRC |
3.6662 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.6659 |
[BP] GO:0007188 |
None
|
ADRA2A, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8 |
3.65706 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, HSD17B1, HSD17B2 |
3.65042 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, DRD1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, RORC, SLC6A4, SRC |
3.5889 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
3.5889 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, DRD2, ESR1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.5889 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, TYR |
3.5889 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.58157 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, FABP3, PPARA, SLC1A1 |
3.56009 |
[BP] GO:0008152 |
metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TYR, XDH |
3.55933 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, HSD17B1, HSD17B2, TYR, XDH |
3.54416 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.54416 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD1, DRD2 |
3.54416 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, FABP3, FABP4, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.53124 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
3.5277 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.5248 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, ADRA2A, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.52024 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4 |
3.49427 |
[BP] GO:0009987 |
cellular process
|
ABCG2, ACHE, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, IGF1R, KCNA3, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
3.46248 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
3.46248 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, PPARA, SLC6A4, SRC |
3.46248 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2 |
3.43301 |
[BP] GO:0044237 |
cellular metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TYR, XDH |
3.38827 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, GRIK5, SLC1A1, SLC6A2, SLC6A4 |
3.38827 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, ADRA2A, AKR1B1, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNH2, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC |
3.37575 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, ADRA2A, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
3.35515 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADRA2A, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
3.34133 |
[BP] GO:0007187 |
None
|
ADRA2A, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8 |
3.31754 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADRA2A, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
3.31473 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADRA2A, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
3.3026 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, ADRA2A, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.28366 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADRA2A, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
3.2806 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4 |
3.17432 |
[BP] GO:1900543 |
None
|
ADRA2A, DRD2, GRM3, GRM8, PPARA |
3.16547 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADRA2A, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
3.16476 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, CYP3A4, HSD17B1, HSD17B2 |
3.16476 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.16145 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.15654 |
[BP] GO:0045980 |
None
|
ADRA2A, DRD2, GRM3, GRM8, PPARA |
3.15508 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA3, AXL, CA1, CSNK2A1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
3.14051 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, ESR1, PPARA, RORC, SLC6A4, SRC |
3.11769 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
2.97382 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, ADRA2A, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.96592 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADRA2A, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, GRIK5, GRM5, KCNA3, KCNH2, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
2.96161 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA3, ADRA2A, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.95625 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADRA2A, AKR1B1, AXL, CSNK2A1, CYP1B1, DRD2, F3, FLT3, GRM1, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
2.95152 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SLC6A4, SRC, TYR |
2.94452 |
[BP] GO:0015872 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.94147 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2C19, CYP3A4 |
2.94147 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADRA2A, AURKB, CDC25B, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.92914 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.83437 |
[BP] GO:0015893 |
None
|
ABCG2, CA2, DRD1, SLC1A1, SLC6A2, SLC6A4 |
2.82952 |
[BP] GO:0007200 |
None
|
ADRA2A, DRD1, DRD2, ESR1, GRM5 |
2.80788 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.80788 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.7531 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, FABP3, PPARA, SLC1A1 |
2.7515 |
[BP] GO:0050801 |
ion homeostasis
|
ABCG2, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, GRM1, GRM5, KCNH2 |
2.7515 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD1, DRD2, ESRRB, GRM3, GRM8, PPARA |
2.74412 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.74252 |
[BP] GO:0030818 |
None
|
ADRA2A, DRD2, GRM3, GRM8 |
2.72507 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT |
2.72507 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADRA2A, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
2.72507 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADRA2A, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
2.72507 |
[BP] GO:0051937 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.68564 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.68564 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD1, DRD2, ESRRB, GRM3, GRM8, PPARA |
2.68564 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.68564 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SLC6A4, SRC, TYR |
2.67994 |
[BP] GO:0030803 |
None
|
ADRA2A, DRD2, GRM3, GRM8 |
2.66871 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADRA2A, DRD1, DRD2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
2.64299 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADRA2A, AKR1B1, AXL, CSNK2A1, CYP1B1, DRD2, ESRRA, F3, FABP4, FLT3, GRM1, KDR, MET, MMP12, MMP2, MMP9, PTPN1, SRC, TERT, XDH |
2.63691 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADRA2A, AKR1B1, AXL, CYP1B1, DRD2, F3, FLT3, GRM1, KDR, MET, PTPN1, SRC, XDH |
2.63691 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADRA2A, DRD1, DRD2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
2.63691 |
[BP] GO:0023052 |
None
|
DRD1, DRD2, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, KCNH2, SLC1A1, SLC6A2 |
2.62916 |
[BP] GO:0030817 |
None
|
ADRA2A, DRD1, DRD2, GRM3, GRM8 |
2.62916 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.62916 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, SLC6A4 |
2.62916 |
[BP] GO:0030815 |
None
|
ADRA2A, DRD2, GRM3, GRM8 |
2.61875 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADRA2A, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, ESR1, F3, FLT3, GRM1, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
2.60251 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.59768 |
[BP] GO:1900372 |
None
|
ADRA2A, DRD2, GRM3, GRM8 |
2.5922 |
[BP] GO:0030809 |
None
|
ADRA2A, DRD2, GRM3, GRM8 |
2.5922 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
CYP1A1, CYP1B1, DRD1, ESR1, FLT3, RORC, SLC6A4, SRC |
2.58677 |
[BP] GO:0001504 |
None
|
SLC1A1, SLC6A2, SLC6A4 |
2.56396 |
[BP] GO:0030800 |
None
|
ADRA2A, DRD2, GRM3, GRM8 |
2.56396 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, ADRA2A, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
2.54993 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, CA2, CYP1A1, DRD1, DRD2, GRM1, MMP2, PPARA, SLC6A4, SRC, TERT, TYR |
2.54593 |
[BP] GO:0001666 |
response to hypoxia
|
CYP1A1, DRD2, MMP2, PPARA, SLC6A4, SRC, TERT |
2.53858 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.52273 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADRA2A, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.49326 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT |
2.49326 |
[BP] GO:0065007 |
biological regulation
|
ABCG2, ACHE, ADORA3, ADRA2A, AKR1B1, AURKB, AXL, CA1, CA12, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, IGF1R, KCNA3, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, XDH |
2.47626 |
[BP] GO:0032787 |
None
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA |
2.47431 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
CYP1A1, DRD2, MMP2, PPARA, SLC6A4, SRC, TERT |
2.46923 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.46923 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.46616 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.46616 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.46616 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.46616 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2 |
2.46616 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.46616 |
[BP] GO:0043269 |
regulation of ion transport
|
ADRA2A, CA2, CA7, DRD1, DRD2, GRM5, KCNA3, KCNH2, MMP9, SLC6A4 |
2.46616 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.45084 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.42574 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.39277 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.38918 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA3, ADRA2A, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MMP9, PTPN1, SRC, TERT, XDH |
2.38918 |
[BP] GO:0007267 |
None
|
DRD1, DRD2, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
2.38004 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KCNH2, KDR, SRC |
2.37277 |
[BP] GO:0030814 |
None
|
ADRA2A, DRD1, DRD2, GRM3, GRM8 |
2.37277 |
[BP] GO:0015844 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.3561 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
2.3304 |
[BP] GO:0030802 |
None
|
ADRA2A, DRD1, DRD2, GRM3, GRM8 |
2.32727 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ABCG2, CA12, CA2, CA7, DRD1, DRD2, ESR1, GRM1, GRM5, KCNH2 |
2.30662 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.30662 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.30662 |
[BP] GO:0070482 |
response to oxygen levels
|
CYP1A1, DRD2, MMP2, PPARA, SLC6A4, SRC, TERT |
2.30584 |
[BP] GO:0042391 |
None
|
DRD1, GRIA2, GRIA4, GRIK5, GRM5, KCNH2, KDR, SRC |
2.2865 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, DRD1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.2618 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.25618 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, DRD1, DRD2, SLC6A4 |
2.24491 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.24162 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, MET, MMP9, PPARA, SRC, TERT |
2.24162 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.24162 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.24162 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.24162 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.23758 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, AURKB, AXL, CA2, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A4, SRC, TERT, TYR |
2.23259 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.22697 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
CA2, CA7, DRD1, DRD2, KDR, SRC |
2.22485 |
[BP] GO:1900371 |
None
|
ADRA2A, DRD1, DRD2, GRM3, GRM8 |
2.20819 |
[BP] GO:0030808 |
None
|
ADRA2A, DRD1, DRD2, GRM3, GRM8 |
2.19551 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, F3, MET, SRC, XDH |
2.19551 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADRA2A, AXL, CA2, CYP19A1, DRD1, DRD2, KCNH2, MMP12, SLC6A4, SRC, TERT |
2.1819 |
[BP] GO:0006082 |
organic acid metabolic process
|
ABCG2, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, TYR |
2.17498 |
[BP] GO:0080134 |
regulation of response to stress
|
ADRA2A, CYP19A1, DRD2, ESR1, F3, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PTPN1, SRC, TERT, XDH |
2.16773 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, DRD1, ESR1, FLT3, GRM5, IGF1R, MMP2, SLC6A4, SRC |
2.13688 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.13688 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.13688 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD17B1, HSD17B2 |
2.12239 |
[BP] GO:0010038 |
response to metal ion
|
CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, TERT |
2.11056 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADRA2A, CYP19A1, DRD1, DRD2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TERT, XDH |
2.09956 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, SLC6A4, SRC |
2.09164 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADRA2A, CDC25B, DRD2, ESRRB, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
2.09164 |
[BP] GO:0051179 |
None
|
ABCG2, ACHE, ADRA2A, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, DRD1, DRD2, ESR1, FABP3, GRIA2, GRIA4, GRIK5, KCNA3, KCNH2, MMP12, MMP9, PPARA, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, XDH |
2.07608 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07608 |
[BP] GO:0034762 |
None
|
ADRA2A, CA2, DRD1, DRD2, GRM5, KCNA3, KCNH2, MMP9 |
2.07086 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.06938 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.06938 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.06938 |
[BP] GO:0051234 |
None
|
ABCG2, ACHE, ADRA2A, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA7, DRD1, DRD2, FABP3, GRIA2, GRIA4, GRIK5, KCNA3, KCNH2, MMP12, MMP9, PPARA, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, XDH |
2.06714 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.06693 |
[BP] GO:0030799 |
None
|
ADRA2A, DRD1, DRD2, GRM3, GRM8 |
2.0557 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, CSNK2A1, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT |
2.03297 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.02636 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, TYR |
2.01816 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA3, ADRA2A, AXL, CA2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, GRM1, KCNH2, KDR, MET, MMP12, MMP9, PIM1, SLC1A1, SLC6A4, SRC, TERT, XDH |
2.01069 |
[BP] GO:0060078 |
None
|
GRIA2, GRIA4, GRIK5, GRM5 |
2.00877 |
[CC] GO:0005886 |
plasma membrane
|
ABCG2, ACHE, ADORA3, ADRA2A, AXL, CA12, CA14, CA2, CA4, CSNK2A1, DRD1, DRD2, ESR1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNA3, KCNH2, KDR, MET, MMP2, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A4, SRC, TERT |
4.64247 |
[CC] GO:0098590 |
plasma membrane region
|
ABCG2, ADRA2A, CA2, CA4, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, SLC1A1, SRC |
4.39634 |
[CC] GO:0044459 |
plasma membrane part
|
ABCG2, ADORA3, ADRA2A, AXL, CA2, CA4, DRD1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNA3, KCNH2, KDR, MET, SLC1A1, SLC6A2, SLC6A4, SRC |
4.25239 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, ADRA2A, AXL, CA4, DRD1, DRD2, F3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A4 |
4.19929 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.4053 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA3, ADRA2A, AXL, DRD1, DRD2, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A4 |
3.31213 |
[CC] GO:0016020 |
membrane
|
ABCG2, ACHE, ADORA3, ADRA2A, ALOX5, AXL, CA12, CA14, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B2, IGF1R, KCNA3, KCNH2, KDR, MET, MMP2, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TYR |
2.83335 |
[CC] GO:0043005 |
None
|
CA2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, KCNA3, SLC6A2, SLC6A4, SRC |
2.79057 |
[CC] GO:0044456 |
None
|
ACHE, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A4, SRC |
2.63691 |
[CC] GO:0044425 |
membrane part
|
ABCG2, ACHE, ADORA3, ADRA2A, AXL, CA12, CA14, CA2, CA4, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B2, IGF1R, KCNA3, KCNH2, KDR, MET, PTPN1, SLC1A1, SLC6A2, SLC6A4, SRC, TYR |
2.4641 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.3304 |
[CC] GO:0014069 |
None
|
DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.30662 |
[CC] GO:0099572 |
None
|
DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.30662 |
[CC] GO:0120025 |
None
|
AKR1B1, CA2, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, KCNA3, SLC6A2, SLC6A4, SRC |
2.11133 |
[CC] GO:0043235 |
receptor complex
|
ABCG2, ADRA2A, GRIA2, GRIA4, GRIK5, GRM1, IGF1R |
2.09164 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
12.4365 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.79432 |
[MF] GO:0043167 |
ion binding
|
ABCG2, ACHE, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
7.76869 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
7.75606 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, ADRA2A, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
7.75606 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, ADRA2A, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
6.7571 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, ADRA2A, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
6.59749 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, ADRA2A, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
6.1041 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, XDH |
5.42323 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, TERT, TYR, XDH |
5.41413 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC |
5.21354 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4 |
5.21354 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.10705 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.05618 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.05618 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC |
5.04611 |
[MF] GO:0003824 |
catalytic activity
|
ABCG2, ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, F3, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, TERT, TYR, XDH |
4.98237 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.91358 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.8399 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, TYR |
4.82827 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.69072 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
4.49266 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, HSD17B1, HSD17B2, TYR, XDH |
4.39634 |
[MF] GO:0008144 |
drug binding
|
ABCG2, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD1, DRD2, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SLC6A4, SRC |
4.39634 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, TERT, TYR, XDH |
4.29805 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.22258 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, SRC |
4.14393 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, SRC |
3.93883 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, ADRA2A, AXL, DRD1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET |
3.82443 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, ADRA2A, AXL, DRD1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET |
3.82443 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, TYR |
3.6662 |
[MF] GO:0042802 |
identical protein binding
|
ABCG2, ACHE, ADRA2A, AOX1, CSNK2A1, DRD2, ESR1, ESR2, FLT3, GRIK5, IGF1R, KCNH2, KDR, MET, MMP9, SLC6A4, TERT, TYR, XDH |
3.62589 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.4053 |
[MF] GO:0008289 |
lipid binding
|
AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD17B1, PPARA, RORC |
3.37452 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.28366 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADRA2A, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC |
3.16476 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, HSD17B1, SRC, XDH |
3.14051 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2C19, CYP3A4 |
3.10441 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B1, HSD17B2, XDH |
3.00164 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.97479 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.80788 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADRA2A, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC |
2.79057 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.72507 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.46923 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.46616 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.46616 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.46616 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.46616 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.46616 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.46616 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.46616 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.45005 |
[MF] GO:1901338 |
None
|
ADRA2A, DRD1, DRD2 |
2.40852 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.40852 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.25618 |
[MF] GO:0042803 |
protein homodimerization activity
|
ABCG2, ACHE, ADRA2A, AOX1, DRD2, FLT3, KCNH2, SLC6A4, TERT, TYR, XDH |
2.2495 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.24162 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.24162 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.24162 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.24162 |
[MF] GO:0099094 |
None
|
GRIA2, GRIA4, GRIK5, KCNH2 |
2.23758 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, SLC6A4 |
2.07608 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.06938 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.06938 |
[MF] GO:0052689 |
carboxylic ester hydrolase activity
|
ACHE, CA1, CA2, CES1, CES2 |
2.0557 |